BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poloyac SM, Bertz RJ, McDermott LA, Marathe P. Pharmacological Optimization for Successful Traumatic Brain Injury Drug Development. J Neurotrauma 2020;37:2435-44. [PMID: 30816062 DOI: 10.1089/neu.2018.6295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yilmaz İ, Karaarslan N, Somay H, Ozbek H, Ates O. Curcumin-Impregnated Drug Delivery Systems May Show Promise in the Treatment of Diseases Secondary to Traumatic Brain Injury: Systematic Review. Journal of Pharmacology and Pharmacotherapeutics. [DOI: 10.1177/0976500x221112479] [Reference Citation Analysis]
2 Nishimura K, Cordeiro JG, Ahmed AI, Yokobori S, Gajavelli S. Advances in Traumatic Brain Injury Biomarkers. Cureus. [DOI: 10.7759/cureus.23804] [Reference Citation Analysis]
3 Lafrenaye A, Mondello S, Povlishock J, Gorse K, Walker S, Hayes R, Wang K, Kochanek PM. Operation Brain Trauma Therapy: An Exploratory Study of Levetiracetam Treatment Following Mild Traumatic Brain Injury in the Micro Pig. Front Neurol 2020;11:586958. [PMID: 33584493 DOI: 10.3389/fneur.2020.586958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]